Home/Filings/4/0001235802-22-000075
4//SEC Filing

Kellen Scott 4

Accession 0001235802-22-000075

CIK 0001401040other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:02 PM ET

Size

6.1 KB

Accession

0001235802-22-000075

Insider Transaction Report

Form 4
Period: 2022-06-01
Kellen Scott
CFO & Secretary
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-01+60,00060,000 total
    Exercise: $2.45Exp: 2032-05-31Common Shares (60,000 underlying)
Holdings
  • Voting Common Shares, no par value per share

    22,290
Footnotes (1)
  • [F1]Vests with respect to 25% of the underlying common shares on June 1, 2023 and with respect to the remaining 75% of the underlying common shares in 36 as nearly equal as possible monthly installments commencing on July 1, 2023.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001490476

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:02 PM ET
Size
6.1 KB